Applied NeuroSolutions To Offer P-Tau 231 Test For Use In Alzheimer’s Disease Clinical Trials

Applied NeuroSolutions, Inc. (OTC BB:APNS)( http://www.AppliedNeuroSolutions.com), a company focused on the development of products for the early diagnosis and treatment of Alzheimer’s disease (”AD”), today announced an initiative to provide its P-Tau 231 cerebrospinal fluid (CSF) test to companies undertaking AD clinical trials.

More: continued here

Filed under: Alzheimer's / Dementia News XML/RSS Feed on May 17th, 2008

Comments are closed.

« Malaysia Considers Providing Sex Education To Participants In National Service Program Distinct Treatment Needed: Tourette’s And Obsessive-Compulsive Disorder, Canada »

Healthy Recipes 4 All - : Healthy Recipes 4 All
Online RX Store - Buy Drugs: Store for Rx products
Order Fioricet Pills - Buy Drugs: Order Fioricet pills
Pay Less for Generic - : Pay Less for Generic
Pills Source - Buy Drugs: Pill source
Pills Store Online - Buy Drugs: Pills sotre online
Quality Generic Pills - : Quality Generic Pills
Discount prescripts - : Discount prescripts
Drug store online - Drug store online: Pills form drugs store online
The world pharmacy - : The world pharmacy
Latest News...